We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mallinckrodt Pharmaceuticals to Acquire Questcor for $5.6B

News   Apr 08, 2014

 
Mallinckrodt Pharmaceuticals to Acquire Questcor for $5.6B
 
 
 

RELATED ARTICLES

A Novel Epstein-Barr Virus-specific T Cell Therapy for Progressive MS

News

Mounting evidence shows that Epstein-Barr virus (EBV) plays a role in the pathology of multiple sclerosis. Consequently, an EBV-specific T Cell therapy has been developed to combat MS, and initial clinical trial results are promising.

READ MORE

Body Scanner Captures 3D Picture of Whole Human Body at Once

News

EXPLORER, the world’s first medical imaging scanner that can capture a 3D picture of the whole human body at once, has produced its first scans.

READ MORE

Oncolytic Adenovirus Modified to Actively Kill 2 Cancerous Cell Types

News

An engineered oncolytic adenovirus that encodes a bispecific antibody harnesses a dual-action approach to attack stromal fibroblasts.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE